The conjunctival epithelium is one of the few tissues in the body that is directly and continuously exposed to solar radiation without a keratin barrier. In the cornea, the epithelium is protected by tear film, maintained by tight junctions, and supported by Langerhans cells that survey for damage. But the limbal zone — the thin ring where conjunctiva meets cornea — is uniquely vulnerable.

UV-B radiation (290–320 nm) is the principal pathogenic driver. When UV-B photons strike conjunctival fibroblasts and epithelial cells, they trigger a cascade now well-characterised at the molecular level:

• p53 tumour suppressor mutation — UV-B induces characteristic C→T and CC→TT transition mutations at dipyrimidine sites in the p53 gene. These mutations — the "UV signature" — have been found in pterygium tissue at rates of 33–77% in published series, confirming UV as the initiating mutagen.
• Limbal stem cell damage — UV depletes the limbal stem cell population that normally maintains the corneal-conjunctival boundary. With impaired stem cell surveillance, conjunctival fibroblasts lose their positional restraint and migrate onto the corneal surface.
• MMP upregulation — Matrix metalloproteinases (MMP-1, MMP-2, MMP-3) are upregulated in pterygium tissue, degrading corneal stromal collagen and the basement membrane, facilitating fibrovascular invasion.
• VEGF overexpression — Vascular endothelial growth factor is significantly elevated in pterygium tissue, explaining the characteristic vascularity. VEGF drives the angiogenesis that sustains the growing fibrovascular mass.
• Nasal predominance — Pterygium occurs on the nasal side (medial canthus) far more commonly than temporal (lateral canthus). The proposed explanation: the "peripheral light-focusing effect" — light entering the eye from the temporal side is focused by the cornea and lens onto the nasal limbus, creating a UV hot spot up to 20× the intensity of the ambient light. This explains why the nasal limbus preferentially accumulates UV damage.

India's latitude (8°–37°N), occupational profile (>60% agriculture and outdoor labour), and climate create ideal conditions for pterygium. UV-B irradiance is 40–60% higher in India's tropical zones than in Northern European latitudes, and outdoor workers receive cumulative UV exposures that would require decades to accumulate in Scandinavian populations.

Three Indian populations deserve particular mention:

• Agricultural workers — paddy farmers, sugarcane workers, and fisherfolk in Tamil Nadu, Andhra Pradesh, Kerala, and coastal Gujarat face 8–10 hours of daily unprotected UV exposure. Pterygium prevalence in studied agricultural cohorts reaches 15–22% in workers over 40.
• Fishermen — ocean and lake fishermen experience UV dose amplification from water surface reflection (adding 15–30% UV to direct solar exposure). Chennai and Kerala fishing communities show some of the highest pterygium rates in any studied Indian population.
• Construction workers — urban construction workers in India's rapidly expanding cities face reflected UV from concrete, glass, and steel surfaces. Pterygium in young male construction workers (20–35) is increasingly common in tertiary eye hospital referral data.

Histologically, a pterygium has three zones: the cap (the avascular leading edge, actually a few millimetres ahead of the visible head on slit-lamp examination), the head (the fibrovascular apex that has crossed the limbus onto the cornea), and the body (the vascular bulk on the sclera). The body's vascularity varies — fleshy, highly vascular pterygia are more likely to be actively growing and to recur after surgery; pale, relatively avascular, flat pterygia are more likely to be stationary. Clinically, documenting the vascularity and degree of elevation is part of surgical planning.

Both pterygium and pinguecula are UV-related conjunctival growths, and patients — and sometimes primary care physicians — confuse them regularly. The distinction is clinically critical because their management and prognosis differ fundamentally.

The characteristic slit-lamp signs of pterygium: a fibrovascular wing originating from the bulbar conjunctiva at the nasal (occasionally temporal) limbus, with a fleshy head extending onto the corneal surface. Key documentation: location (nasal/temporal/bilateral), size (mm of corneal invasion), elevation (flat vs elevated — elevated correlates with more active disease), vascularity (pale vs fleshy/congested), and the presence of Stocker's line — an iron deposition line at the advancing edge of the pterygium head in the corneal epithelium. A Stocker's line indicates a slow-growing, stationary pterygium; its absence correlates with active progression.

Corneal topography (Pentacam, Orbscan) is essential for any pterygium with suspected Grade 2+ disease — it documents the induced astigmatism, corneal power irregularity, and provides a baseline for monitoring progression and evaluating post-surgical refraction change. Any patient being assessed for concurrent cataract surgery and pterygium should have topography-guided IOL power calculation; pterygium induces significant irregular astigmatism that confounds conventional keratometry.

Fluorescein staining — using FLUROSCÉNE ophthalmic strips — reveals epithelial staining at the pterygium leading edge and maps any associated dry eye surface damage. The overlap between pterygium and dry eye disease is significant: the pterygium disrupts tear film stability, creates a mechanical barrier to normal tear spreading, and the chronic surface inflammation drives goblet cell loss. See our Dry Eye Disease guide for the full diagnostic framework.

Grade 1–2 pterygia, those in elderly patients with high surgical risk, or those in patients who decline surgery — can be managed conservatively with the goal of reducing symptoms, slowing progression, and monitoring for indicators requiring surgical intervention.

• UV protection: Wrap-around sunglasses with UV-400 protection are the most evidence-based intervention for pterygium prevention and progression slowing. UV protection should be recommended to all pterygium patients as lifetime habit — particularly relevant for India's outdoor-worker population. Wide-brimmed hats reduce superior UV exposure. UV blocking contact lenses provide additional protection in cooperative patients.
• Preservative-free artificial tears: Lubricants reduce the mechanical irritation and surface dryness that promotes pterygium inflammation and progression. They also manage the dry eye overlap. Preservative-free essential for patients needing >4 daily applications. Cold compresses reduce episodic congestion.
• Vasoconstrictor/decongestant drops: For patients troubled by the cosmetic appearance or acute conjunctival redness during pterygium flare. ALPHRIN (brimonidine) reduces conjunctival hyperaemia and surface congestion. Short-term use for cosmetically significant redness episodes; not for chronic daily use.
• Short-course topical steroids: For acute pingueculitis or pterygium inflammatory flare — fluorometholone 0.1% or loteprednol 0.5% for 1–2 weeks. IOP monitoring mandatory. Never for chronic unsupervised use. Steroid-induced glaucoma from pterygium management is a documented problem in India (covered in detail in our Glaucoma guide).
• Surgical referral triggers: Any of: progression (>0.5 mm/year), Grade ≥3, induced astigmatism ≥2D, symptomatic diplopia, mechanical restriction of motility, cosmetic distress significantly impacting quality of life, pre-cataract surgery planning (pterygium must be excised first and corneal topography must stabilise — typically 3–6 months post-pterygium excision — before accurate IOL power calculation).

Pterygium surgery has evolved dramatically over the past 30 years. The shift from bare sclera excision (the historical standard) to conjunctival autograft transplantation represents one of the most evidence-supported technique changes in ophthalmic surgery — reducing recurrence rates from ~50% to under 10% at experienced centres.

The success of conjunctival autograft depends on two technical principles: precise graft size matching and orientation-correct placement. The graft is harvested from the superior bulbar conjunctiva (dissecting close to Tenon's capsule to minimise Tenon's tissue contamination), sized to exactly match the scleral defect, and secured either with 10-0 nylon sutures at the four corners or fibrin glue. The limbal edge of the graft — containing limbal stem cells — should be placed at the limbal edge of the recipient site. Inadvertent inversion of the graft (placing the limbal edge toward the fornix) doubles the recurrence rate.

OP-BLADE microsurgical blades are used for the precise conjunctival dissection and graft harvesting required in CAT — the quality of the blade edge directly affects how cleanly Tenon's capsule is separated from the conjunctival graft. Tenon's contamination in the graft (Tenon's capsule fibroblasts are highly active) is one of the most common preventable causes of higher recurrence after technically "successful" CAT.

Post-operative antibiotic prophylaxis is essential. In pterygium surgery — where the bare scleral surface (even when grafted) represents a potential portal of entry — intracameral or topical antibiotic cover reduces infection risk. MOXGUARD (intracameral moxifloxacin) is used at Agaaz-affiliated centres for combined procedures (pterygium + cataract) and in centres applying this prophylaxis protocol to pterygium-only excision with high-risk features.

Recurrent pterygium — regrowth of fibrovascular tissue across the excision site within months to 2 years of surgery — is the principal clinical challenge in pterygium management. Recurrent pterygia are typically more aggressive, more vascular, more fibrotic, and more technically difficult to excise than primary disease. Every recurrence narrows the surgical options and worsens the prognosis.

• Young age — patients under 40 have 2–3× higher recurrence rates than patients over 60, likely due to higher fibroblast proliferative capacity and more active wound healing response.
• Indian/tropical ethnicity — pigmented races and tropical populations have higher UV-adapted conjunctival fibroblast activity. This is a strong, well-documented independent predictor.
• Large pterygium size — head extent >3mm onto cornea at excision correlates with higher recurrence.
• Highly vascular/fleshy body — indicates active disease with higher inflammatory mediator load.
• Surgical technique — bare sclera >> CAT. This is the most modifiable risk factor.
• Continued UV exposure post-surgery — patients who return to outdoor work without UV protection have dramatically higher recurrence rates.
• Ongoing dry eye — the inflamed, unstable ocular surface promotes pterygium recurrence by the same mechanisms that drove primary disease.
• Recurrent vs primary pterygium — every prior excision increases recurrence risk for the next procedure. Third and fourth recurrences are often essentially unsalvageable by standard techniques.